Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Innoviva Inc (NQ: INVA )

19.26 -0.30 (-1.53%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Innoviva Inc

< Previous 1 2 3 4 Next >
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers 
Via Benzinga
Theravance Biopharma, Innoviva Gain On Selling TRELEGY ELLIPTA Royalty Interests
Via Benzinga
Innoviva Sells 15% Economic Stake in Theravance Respiratory Company to Royalty Pharma for approximately $282 million plus full ownership of existing equity investments and the potential for $50 million milestone payment
From Innoviva, Inc.
Via Business Wire
La Jolla Pharmaceutical (LJPC) Stock Skyrockets on Innoviva Acquisition News
A headline-grabbing takeover deal could be impactful for the medical community - and today, it's definitely huge news for LJPC stock holders. 
Via InvestorPlace
Innoviva Acquires AstraZeneca-Spin Off At $2.20/Share
Via Benzinga
Innoviva Completes Acquisition of Entasis Therapeutics
From Innoviva, Inc.
Via Business Wire
The Daily Biotech Pulse: Europe Approves Second Round Of Booster Doses of mRNA COVID-19 Vaccines, Perrigo Seeks Approval For First OTC Birth Control Pill, MacroGenics Closes Head & Cancer Study After Patient Death
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Innoviva Bolsters Its Infectious Disease, Hospital Portfolio With La Jolla Deal
Via Benzinga
Innoviva to Acquire La Jolla Pharmaceutical Company
From La Jolla Pharmaceutical Company
Via Business Wire
Innoviva Announces Expiration of Cash Tender Offer for Shares of Entasis Therapeutics Holdings Inc.
From Innoviva, Inc.
Via Business Wire
5 Value Stocks To Watch In The Healthcare Sector
What Defines a Value Stock? 
Via Benzinga
Innoviva to Acquire Entasis Therapeutics
From Innoviva, Inc.
Via Business Wire
Innoviva Reports First Quarter 2022 Financial Results
From Innoviva, Inc.
Via Business Wire
Overview Of Value Stocks In The Healthcare Sector
What are Value Stocks? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be... 
Via Benzinga
Sail Through the Choppy Market With These 4 Low-Beta Stocks
Creating a portfolio of low-beta stocks is important since the securities can deliver healthy returns and provide a shield against volatile market conditions. 
Via Talk Markets
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Dermata Therapeutics (NASDAQ:DRMA) stock rose 29.0% to $1.38 during Friday's pre-market session. The company's market cap stands at $11.4 million. Innoviva... 
Via Benzinga
The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
62 Biggest Movers From Yesterday
Gainers American Rebel Holdings, Inc. (NASDAQ: AREB) shares jumped 42.8% to close at $3.07 on Thursday following the company's recent uplisting to the Nasdaq.... 
Via Benzinga
Armata Pharma's Largest Shareholder Injects $45M For Its Bacteriophage Development
Armata Pharmaceuticals Inc (NYSE: ARMP) has  
Via Benzinga
Innoviva Reports Fourth Quarter 2021 Financial Results
From Innoviva, Inc.
Via Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Good morning, investor! We're beginning another busy day of trading with a look at the biggest pre-market stock movers for Wednesday! 
Via InvestorPlace
10 Stocks to Buy That Could Make You a Millionaire in 2022
After this past year, it's going to be hard to find stocks to buy to make you a millionaire in 2022. Here are 10 that might do the trick. 
Via InvestorPlace
7 of the Top-Rated Pharmaceutical Stocks for Q1
As the market begins to shift from high-growth, tech-fueled start-ups, one good long-term growth option is quality pharmaceutical stocks. 
Via InvestorPlace
5 Value Stocks In The Healthcare Sector
What is a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be... 
Via Benzinga
5 Value Stocks To Watch In The Healthcare Sector
What is a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples... 
Via Benzinga
Innoviva Reports Third Quarter 2021 Financial Results
From Innoviva, Inc.
Via Business Wire
Beam Therapeutics Stock Flashes Renewed Technical Strength
On Tuesday, Beam Therapeutics stock reached an key performance benchmark, seeing its RS Rating jump to 92, up from 88 the day before. 
Via Investor's Business Daily
Innoviva Stock In Buy Range; Joins Ranks Of Top-Performing Stocks With Strength Ratings Over 90
Innoviva stock is within a buy range after climbing above a 16.82 entry in a flat base. The proper buying range is up to 5% above the entry. 
Via Investor's Business Daily
Alkermes Stock Composite Rating Rises To Near-Perfect 96 As It Posts Erratic But Huge Sales Gains
The IBD SmartSelect Composite Rating for Alkermes rose from 94 to 96 Tuesday. 
Via Investor's Business Daily
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 29) Acceleron Pharma Inc. (... 
Via Benzinga
Exposures COVID-19
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.